Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 2Carcinoma, Renal Cell 2Weight Loss 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Apnea Syndromes 1Sezary Syndrome 1Sarcoma 1Recurrence 1Overweight 1Obesity, Morbid 1Obesity 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Hypertension 1Hyperlipidemias 1Hemangioma 1Gastroesophageal Reflux 1Eczema 1Disease 1Digestive System Diseases 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Dermatitis, Atopic 1Collagen Diseases 1

Interventions

Cyclophosphamide 153Dexamethasone 141Rituximab 85fludarabine 79Lenalidomide 72Cytarabine 70Bortezomib 64fludarabine phosphate 63Gemcitabine 62venetoclax 54Etoposide 53pomalidomide 52pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Urine Specimen Collection × Clear all
NCT06046131 2025-11-17

KP-CARAIBES

Centre Hospitalier Universitaire de la Guadeloupe

Phase NA Recruiting
3,000 enrolled
Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡